Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice

Maria A. Croyle, Ami Patel, Kaylie N. Tran et al. · 2008

Read Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice by Maria A. Croyle, Ami Patel, Kaylie N. Tran et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003548.txt.

Description

Maria A. Croyle and co-authors delivered a vaccine through the nose in this 2008 mouse study. Many people already have immunity to adenovirus type 5. That virus is a popular carrier for vaccine genes. Prior immunity can blunt a vaccine built on it.

The team compared muscle, nose, and oral delivery routes in mice. The vaccine expressed an Ebola surface protein for the tests. Nasal delivery bypassed the pre-existing immunity problem. It also improved the immune response over other routes. The nose route also avoids needles, which could help mass vaccine drives.

Catalog record

CREATORMaria A. Croyle, Ami Patel, Kaylie N. Tran et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003548

Browse the full library · About the Tower of Babel